News, 19 December 2011
On 16 December 2011, the FCA approved a concentration in which Terveystalo Healthcare Oy acquires control of Lääkäriasema Pulssi Oy operating in Turku. Pulssi’s owner shares in subsidiaries and affiliated companies also transfer to Terveystalo.
The FCA investigated the effects of the concentration on the markets of occupational health care services, procurement services, insurance company services and medical services offered to private customers. In its investigations, the FCA concluded that the concentration does not significantly impede effective competition in the Finnish markets or a substantial part thereof as referred to in Section 25 of the Competition Act. According to the office, even after the arrangement, the new concentration has strong competitors in the subregion of Turku in all the relevant markets, such as Mehiläinen for instance.
The effects of the concentration were assessed under the provisions on the control of concentrations of the new Competition Act, which became effective on 1 November 2011. Under the new law, the FCA may, when necessary – and this is contrary to before – also intervene with concentrations in which a dominant position does not arise. A sufficient justification is now the mere prevention of effective competition. In the concentration between Terveystalo and Pulssi, this threshold for intervention was not exceeded, however.
The decision by the office contains business secrets by the parties and can only be published after these have been removed, i.e. in roughly two week’s time.
Research Officer Kaisa Kokko
Assistant Director Timo Mattila